GT Biopharma, Inc. (GTBP) vs Intensity Therapeutics Inc. (INTS)
GT Biopharma, Inc. and Intensity Therapeutics Inc. are both Biotechnology companies. GT Biopharma, Inc. and Intensity Therapeutics Inc. are of similar size ($12.7M and $12.3M). Across the 10 metrics below, Intensity Therapeutics Inc. leads on 6 and GT Biopharma, Inc. on 4.
Valuation
Profitability
| Metric | GTBP | INTS | Biotechnology median |
|---|---|---|---|
| Gross margin | 41.67% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 102.03% | (195.88%) | (57.72%) |
| Return on assets | (176.27%) | (139.85%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack